TNKS and colorectal cancer: Targeting TNKS by small molecule inhibitors including XAV939 [49] and WIKI4 [229] inhibits Wnt signaling and suppresses the malignant phenotypes including anchorage-independent growth in colorectal cancer cells, suggesting that TNKS is a potential target for treatment of Wnt-dependent cancers.